Apellis International GmbH
Pharmaceuticals · Zug, Zug
Apellis International GmbH is a Swiss pharmaceuticals company based in Zug, Canton of Zug, listed in the Swiss commercial register since 2019 (UID CHE-200.662.403).
Board members & signatories
- Leslie Meltzer — Geschäftsführer
- Nur Nicholson — Geschäftsführer
- David Watson — Vorsitzender der Geschäftsführung
Registered purpose
Die Gesellschaft bezweckt Forschungs- und Entwicklungsarbeit eines Biotechnologieunternehmens durchzuführen, Beratungsleistungen zu erbringen und Produkte in den Gebieten der Biotechnologie, der Medizin und verwandter Branchen zu vertreiben; vollständige Zweckumschreibung gemäss Statuten…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What Apellis International does
OFFERING
Apellis International GmbH focuses on developing therapies for geographic atrophy and other diseases driven by the complement system. The company is engaged in research and development of targeted C3 therapies, which aim to address conditions in various medical fields including ophthalmology, haematology, nephrology, and neurology.
Unlock the full analysis →Similar companies
- AC Immune AG — Biotechnology · Lausanne
- Aurealis Therapeutics AG — Biotechnology · Zug
- PreComb Therapeutics AG — Pharmaceuticals · Hombrechtikon
- Engimmune Therapeutics AG — Biotechnology · Allschwil
- Neurimmune AG — Biotechnology · Schlieren
- ImmunOs Therapeutics AG — Pharmaceuticals · Schlieren
Find every pharmaceuticals company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned pharmaceuticals companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime